599 related articles for article (PubMed ID: 32387332)
21. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
22. The Russian vaccine for COVID-19.
Burki TK
Lancet Respir Med; 2020 Nov; 8(11):e85-e86. PubMed ID: 32896274
[No Abstract] [Full Text] [Related]
23. Vaccine designers take first shots at COVID-19.
Cohen J
Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
[No Abstract] [Full Text] [Related]
24. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
25. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
[No Abstract] [Full Text] [Related]
26. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
27. The race for coronavirus vaccines: a graphical guide.
Callaway E
Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
[No Abstract] [Full Text] [Related]
28. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
29. Full Throttle: COVID-19 Open Science to Build Planetary Public Goods.
Von Schomberg R; Özdemir V
OMICS; 2020 Sep; 24(9):509-511. PubMed ID: 32628565
[No Abstract] [Full Text] [Related]
30. Riding the coronacoaster of uncertainty.
The Lancet Infectious Diseases
Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
[No Abstract] [Full Text] [Related]
31. Animal models for COVID-19.
Muñoz-Fontela C; Dowling WE; Funnell SGP; Gsell PS; Riveros-Balta AX; Albrecht RA; Andersen H; Baric RS; Carroll MW; Cavaleri M; Qin C; Crozier I; Dallmeier K; de Waal L; de Wit E; Delang L; Dohm E; Duprex WP; Falzarano D; Finch CL; Frieman MB; Graham BS; Gralinski LE; Guilfoyle K; Haagmans BL; Hamilton GA; Hartman AL; Herfst S; Kaptein SJF; Klimstra WB; Knezevic I; Krause PR; Kuhn JH; Le Grand R; Lewis MG; Liu WC; Maisonnasse P; McElroy AK; Munster V; Oreshkova N; Rasmussen AL; Rocha-Pereira J; Rockx B; Rodríguez E; Rogers TF; Salguero FJ; Schotsaert M; Stittelaar KJ; Thibaut HJ; Tseng CT; Vergara-Alert J; Beer M; Brasel T; Chan JFW; García-Sastre A; Neyts J; Perlman S; Reed DS; Richt JA; Roy CJ; Segalés J; Vasan SS; Henao-Restrepo AM; Barouch DH
Nature; 2020 Oct; 586(7830):509-515. PubMed ID: 32967005
[TBL] [Abstract][Full Text] [Related]
32. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
33. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections.
Soriano V; Barreiro P
AIDS Rev; 2020 Jul; 22(2):124-127. PubMed ID: 32628223
[TBL] [Abstract][Full Text] [Related]
34. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
35. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
Gaebler C; Nussenzweig MC
Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
[No Abstract] [Full Text] [Related]
36. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
Boudjelal M; Nehdi A; Islam I
Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
[No Abstract] [Full Text] [Related]
37. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C; Yi Y; Li J
Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
[No Abstract] [Full Text] [Related]
38. Risk estimation of the SARS-CoV-2 acute respiratory disease outbreak outside China.
Kim S; Choi S; Ko Y; Ki M; Jung E
Theor Biol Med Model; 2020 Jun; 17(1):9. PubMed ID: 32498721
[TBL] [Abstract][Full Text] [Related]
39. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
Banerjee AK; Arora N
Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
[No Abstract] [Full Text] [Related]
40. COVID-19 vaccine development and the way forward.
Arora NK; Das MK
Indian J Public Health; 2020 Jun; 64(Supplement):S108-S111. PubMed ID: 32496238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
